I couldnt lift my arm over my shoulder
Association between Different GLP-1 Receptor Agonists and Gastrointestinal Adverse Reactions: A Real-World Disproportionality Study Based on FDA Adverse Event Reporting System Database. Frontiers in Endocrinology, vol
Other injectable medications are being studied, but these three remain the most widely prescribed and proven choices today
Patients were prescribed either the GLP-1 agonists liraglutide or semaglutide or other weight-loss drugs (OWLDs) including lorcaserin, sibutramine, setmelanotide, fenfluramine, mazindol, orlistat, phentermine and diethylpropion
However, patients using additional diabetes medications should monitor blood glucose carefully and may require dose adjustments of other agents
Short-acting GLP-1RAs, such as lixisenatide, maintain robust effects on gastric emptying, whereas long-acting agents, like liraglutide and semaglutide, exhibit reduced efficacy due to continuous receptor activation